Abstract:Human beta-defensin-4 (hBD4) is a cationic 50-amino acid antimicrobial peptide with three conserved cysteine disulfide bonds. It exhibits a broad antimicrobial spectrum. This study describes the synthesis of hBD4 gene, the heterologous fusion expression of the peptide in Escherichia coli, and the bioactive assay of released hBD4. A PCR-based gene SOEing (splicing by overlap extension) synthesis method was used in the synthesis of the hBD4 gene with optimized codons. By constructing the expression plasmid (pET32-smhBD4), high concentration of soluble hBD4 fusion protein (1.9 g/l) can be obtained in E. coli. Further optimization studies showed that the expression system was very efficient to produce soluble target protein, and the solubility of the target protein could attain more than 99% even when the culture temperature was as high as 37 degrees C. The highest productivity (2.68 g/l) of the hBD4 fusion protein was achieved by cultivating the E. coli (pET32-smhBD4) in MBL medium at 34 degrees C, inducing the culture at the mid-exponential phase with 0.4-mM isopropyl beta-D-galactopyranoside (IPTG), and collecting the broth after 6-h expression. The soluble target protein accounted for 64.6% of the total soluble proteins, and the mature hBD4 expression level was stoichiometrically estimated to be 0.689 g/l. This fusion protein was then purified and cleaved to get the mature hBD4 peptide that showed antimicrobial activity against E. coli and Pseudomonas aeruginosa.

Expression and purification of moricin CM4 and human β-defensins 4 in Escherichia coli using a new technology.

Heterologous Expression and Purification of Dermaseptin S4 Fusion in Escherichia Coli and Recovery of Biological Activity.

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Expression in Escherichia coli and purification of bioactive antibacterial peptide ABP-CM4 from the Chinese silk worm, Bombyx mori

Recombinant Expression of Antimicrobial Peptides Using a Novel Self-Cleaving Aggregation Tag Inescherichia Coli

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Recombinant expression of a novel antimicrobial peptide consisting of human α-defensin 5 and Mytilus coruscus mytilin-1 in Escherichia coli

Fusion Expression of Antibacterial and Antitumorial Peptide CM4N in Escherichia Coli and Its Activity Identification

Expressing Antimicrobial Peptide Cathelicidin-Bf in Bacillus Subtilis Using Sumo Technology

Design and production of a novel antimicrobial fusion protein in Escherichia coli

Expression of a Cytotoxic Cationic Antibacterial Peptide in Escherichia Coli Using Two Fusion Partners

[Fusion Expression of Antimicrobial Peptides in Escherichia Coli].

The Molecular Design of a Recombinant Antimicrobial Peptide CP and Its in Vitro Activity

Expression and Purification of an Antimicrobial Peptide, Bovine Lactoferricin Derivative LfcinB-W10 in Escherichia Coli

A Novel Secretion and Online-Cleavage Strategy for Production of Cecropin A in Escherichia Coli.

Soluble Fusion Expression and Characterization of Human Beta-Defensin 3 Using a Novel Approach.

Cloning Expression and Characterization of a Bi-functional Antibacterial Peptides CM4 and hsBAFF Fusion Protein in Escherichia Coli

A Eukaryotic Expression Strategy for Producing the Novel Antimicrobial Peptide PRW4

Prokaryotic Expression and Activity Identification of Hybrid Peptide HMCM

SUMO Mediating Fusion Expression of Antimicrobial Peptide CM4 from two Joined Genes in Escherichia coli

Expression of Antibacterial Peptide CM4 in Escherichia Coli Fused with Human Soluble B Lymphocyte Stimulator Activing Factor